Macedo E, Bouchard J, Mehta R L
Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, CA, USA.
Minerva Urol Nefrol. 2009 Sep;61(3):189-204.
Renal replacement therapy became a common clinical tool to treat patients with severe acute kidney injury (AKI) since the 1960s. During this time dialytic options have expanded considerably; biocompatible membranes, bicarbonate dialysate and dialysis machines with volumetric ultrafiltration control have improved the treatment for acute kidney injury. Along with advances in methods of intermittent hemodialysis, continuous renal replacement therapies have gained widespread acceptance in the treatment of dialysis-requiring AKI. However, many of the fundamental aspects of the renal replacement treatment such as indication, timing of dialytic intervention, and choice of dialysis modality are still controversial and may influence AKI patient's outcomes. This review outlines current concepts in the use of dialysis techniques for AKI and suggests an approach for selecting the optimal method of renal replacement therapy.
自20世纪60年代以来,肾脏替代疗法已成为治疗重症急性肾损伤(AKI)患者的常用临床手段。在此期间,透析选择有了显著扩展;生物相容性膜、碳酸氢盐透析液以及具备容量超滤控制功能的透析机改善了急性肾损伤的治疗。随着间歇性血液透析方法的进步,连续性肾脏替代疗法在治疗需要透析的AKI方面已得到广泛认可。然而,肾脏替代治疗的许多基本方面,如适应症、透析干预时机以及透析方式的选择,仍存在争议,且可能影响AKI患者的预后。本综述概述了目前用于AKI的透析技术概念,并提出了一种选择最佳肾脏替代治疗方法的途径。